Weiss Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-38,094
Closed -$2.31M – 661
2026
Q1
$2.31M Buy
+38,094
New +$2.22M 0.04% 251
2025
Q4
– Sell
-73,479
Closed -$3.31M – 612
2025
Q3
$3.31M Buy
+73,479
New +$3.43M 0.04% 198
2025
Q2
– Sell
-152,646
Closed -$9.31M – 425
2025
Q1
$9.31M Buy
+152,646
New +$8.9M 0.19% 72
2021
Q3
– Sell
-83,608
Closed -$5.59M – 509
2021
Q2
$5.59M Buy
+83,608
New +$5.45M 0.14% 195
2021
Q1
– Sell
-5
Closed – – 503
2020
Q4
$0 Buy
+5
New +$307 ﹤0.01% 308
2020
Q1
– Sell
-3,870
Closed -$248K – 221
2019
Q4
$248K Buy
+3,870
New +$222K 0.02% 197

Other funds holding BMY

Weiss Asset Management's BMY Position: Q2 2026 in Review

Weiss Asset Management sold out of Bristol-Myers Squibb (BMY) in Q2 2026, closing a stake of 38,094 shares — an estimated $2.31M sold.

Weiss Asset Management first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $9.31M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Weiss Asset Management reported no remaining Bristol-Myers Squibb position as of Q2 2026 after selling out during the quarter.
  • Weiss Asset Management sold 38,094 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.31M.
  • Weiss Asset Management first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
  • Weiss Asset Management's Bristol-Myers Squibb position peaked at $9.31M in Q1 2025.
  • 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Weiss Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.